https://www.marketscreener.com/quote/stock/REMEGEN-CO-LTD-119080101/news/RemeGen-Co-Ltd-Presents-Oral-Presentation-on-Evaluation-of-its-Proprietary-Disitamab-Vedotin-for-C-46158386/?utm_source=telegram&utm_medium=social&utm_campaign=share